Journal of Molecular Biomarkers & Diagnosis

OMICS Publishing Group

Not yet evaluated

About the journal

Journal of Molecular Biomarkers & Diagnosis is an open-access journal published by OMICS Publishing Group in United States. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
OMICS Publishing Group
ISSN
2155-9929
Country
United States
Access
Open access

Index listings

  • PUBMED · 2012-07-02
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Dormant — no works recorded since 2021
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

930

Last recorded publication year

2022

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

20

i10-index

63

From OpenAlex open data (CC0).

Editorial & policy2
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity2
Alternate titles
Journal of molecular biomarkers and diagnosisJMBD
Source type
journal
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Advanced Proteomics Techniques and Applications
  • Breast Cancer Treatment Studies
  • Advanced Biosensing Techniques and Applications
  • Biomarkers in Disease Mechanisms
  • Metabolomics and Mass Spectrometry Studies
Show all subjects (75)
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • MicroRNA in disease regulation
  • Clinical Laboratory Practices and Quality Control
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Advanced Proteomics Techniques and Applications
  • Advanced Proteomics Techniques and Applications
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Genetic Associations and Epidemiology
  • Cancer Cells and Metastasis
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Carcinogens and Genotoxicity Assessment
  • Cancer, Lipids, and Metabolism
  • Breast Lesions and Carcinomas
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Advanced Biosensing Techniques and Applications
  • Cancer, Lipids, and Metabolism
  • Advanced Biosensing Techniques and Applications
  • Metabolomics and Mass Spectrometry Studies
  • Metabolomics and Mass Spectrometry Studies
  • Gene expression and cancer classification
  • Genetic factors in colorectal cancer
  • RNA modifications and cancer
  • Cancer Cells and Metastasis
  • Radiomics and Machine Learning in Medical Imaging
  • RNA modifications and cancer
  • Genomics and Rare Diseases
  • Advanced biosensing and bioanalysis techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Cells and Metastasis
  • Molecular Biology Techniques and Applications
  • Molecular Biology Techniques and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Colorectal Cancer Treatments and Studies
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Head and Neck Cancer Studies
  • Liver Disease Diagnosis and Treatment
  • Health, Environment, Cognitive Aging
  • Liver Disease Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • Gene expression and cancer classification
  • Bioinformatics and Genomic Networks
  • Cancer-related Molecular Pathways
  • Gene expression and cancer classification
  • Genetics, Bioinformatics, and Biomedical Research
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • HER2/EGFR in Cancer Research
  • Bioinformatics and Genomic Networks
  • Bioinformatics and Genomic Networks
  • HER2/EGFR in Cancer Research
  • Diabetes and associated disorders
  • Diabetes and associated disorders
  • Circular RNAs in diseases
  • Nutrition, Genetics, and Disease
  • Circular RNAs in diseases
  • Nutrition, Genetics, and Disease
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: